Literature DB >> 27679596

Utility of near-infrared spectroscopy for detection of thin-cap neoatherosclerosis.

Tomasz Roleder1,2,3, Keyvan Karimi Galougahi1, Chee Yang Chin1,2, Navdeep K Bhatti1, Emmanouil Brilakis4, Tamim M Nazif1,2, Ajay J Kirtane1,2, Dimitri Karmpaliotis1,2, Wojciech Wojakowski3, Martin B Leon1,2, Gary S Mintz2, Akiko Maehara1,2, Gregg W Stone1,2, Ziad A Ali1,2.   

Abstract

AIMS: Near-infrared spectroscopy (NIRS) has been employed to assess the composition of the atherosclerotic plaques in native coronary arteries. However, little is known about the detection of neoatherosclerosis by NIRS in in-stent restenosis (ISR). The aim of the study was to assess the relationship between the distribution of lipid determined by NIRS and morphology of ISR on optical coherence tomography (OCT). METHODS AND
RESULTS: We performed both NIRS and OCT in 39 drug-eluting stents with ISR. Values of lipid-core burden index (LCBI) derived by NIRS were compared with the OCT-derived thickness of the fibrous cap covering neoatherosclerotic lesions. A total of 22 (49%) in-stent neointimas were identified as lipid rich by both NIRS and OCT. There was good agreement between OCT and NIRS in identifying lipid within in-stent neointima (kappa = 0.60, 95% CI: 0.34-0.86). OCT identified thin-cap neoatheromas (TCNA) (<65 µm) in 12 stents (23%). The minimal cap thickness of in-stent neoatherosclerotic plaque measured by OCT correlated with the maxLCBI4mm (maximal LCBI per 4 mm) within the stent (r = -0.77, P< 0.01). Moreover, maxLCBI4mm was able to accurately predict TCNA with a cut-off value of >144.
CONCLUSION: NIRS correlates with OCT identification of lipids in stented vessels and is able to predict the presence of thin fibrous cap neoatheroma. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  in-stent restenosis; near-infrared spectroscopy; optical coherence tomography

Mesh:

Year:  2017        PMID: 27679596      PMCID: PMC5837712          DOI: 10.1093/ehjci/jew198

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  27 in total

1.  Coronary plaque classification with intravascular ultrasound radiofrequency data analysis.

Authors:  Anuja Nair; Barry D Kuban; E Murat Tuzcu; Paul Schoenhagen; Steven E Nissen; D Geoffrey Vince
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

2.  Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.

Authors:  Kousuke Hattori; Yukio Ozaki; Tevfik F Ismail; Masanori Okumura; Hiroyuki Naruse; Shino Kan; Makoto Ishikawa; Tomoko Kawai; Masaya Ohta; Hideki Kawai; Tousei Hashimoto; Yasushi Takagi; Junichi Ishii; Patrick W Serruys; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

3.  Very late bare metal stent thrombosis due to neoatherosclerotic plaque rupture: an optical coherence tomography finding.

Authors:  Johan Bennett; Mark Coosemans; Tom Adriaenssens
Journal:  Heart       Date:  2012-05-30       Impact factor: 5.994

4.  High-Risk Stents Harboring Neoatherosclerosis: Light From Near-Infrared Spectroscopy?

Authors:  Farouc A Jaffer
Journal:  Circ Cardiovasc Imaging       Date:  2016-01       Impact factor: 7.792

5.  Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.

Authors:  Ji-Yong Jang; Jung-Sun Kim; Dong-Ho Shin; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Atherosclerosis       Date:  2015-08-12       Impact factor: 5.162

6.  Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents.

Authors:  Ziad A Ali; Tomasz Roleder; Jagat Narula; Bibhu D Mohanty; Usman Baber; Jason C Kovacic; Gary S Mintz; Fumiyuki Otsuka; Stephen Pan; Renu Virmani; Samin K Sharma; Pedro Moreno; Annapoorna S Kini
Journal:  Circ Cardiovasc Interv       Date:  2013-09-24       Impact factor: 6.546

7.  Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT.

Authors:  Tomasz Roleder; Jason C Kovacic; Ziad Ali; Raman Sharma; Ecatarina Cristea; Pedro Moreno; Samin K Sharma; Jagat Narula; Annapoorna S Kini
Journal:  EuroIntervention       Date:  2014-07       Impact factor: 6.534

8.  Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.

Authors:  Ryoji Nagoshi; Toshiro Shinke; Hiromasa Otake; Junya Shite; Daisuke Matsumoto; Hiroyuki Kawamori; Masayuki Nakagawa; Amane Kozuki; Hirotoshi Hariki; Takumi Inoue; Tsuyoshi Ohsue; Yu Taniguchi; Masamichi Iwasaki; Ryo Nishio; Noritoshi Hiranuma; Akihide Konishi; Hiroto Kinutani; Naoki Miyoshi; Tomofumi Takaya; Shinichiro Yamada; Yoshinori Yasaka; Takatoshi Hayashi; Mitsuhiro Yokoyama; Hiroki Kato; Makoto Kadotani; Yoshio Ohnishi; Ken-ichi Hirata
Journal:  Circ J       Date:  2012-12-21       Impact factor: 2.993

Review 9.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

10.  Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system.

Authors:  Craig M Gardner; Huwei Tan; Edward L Hull; Jennifer B Lisauskas; Stephen T Sum; Thomas M Meese; Chunsheng Jiang; Sean P Madden; Jay D Caplan; Allen P Burke; Renu Virmani; James Goldstein; James E Muller
Journal:  JACC Cardiovasc Imaging       Date:  2008-09
View more
  1 in total

Review 1.  Hypersensitivity and in-stent restenosis in coronary stent materials.

Authors:  Wansong Hu; Jun Jiang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.